Alembic receives USFDA approval for Dexlansoprazole delayed-release capsules EP News Bureau Nov 13, 2025 Alembic Pharmaceuticals secures final USFDA approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg,…
